Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dehydroepiandrosterone 75 SR
Therapeutic Category
Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹390/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ovaflip is a specialized formulation containing Dehydroepiandrosterone (DHEA) in a sustained-release (SR) format, designed to support hormonal balance and overall well-being. DHEA is a naturally occurring hormone produced by the adrenal glands, playing a crucial role in the synthesis of other hormones, including testosterone and estrogen. As individuals age, DHEA levels tend to decline, which can lead to various health issues. Ovaflip aims to replenish these levels, potentially enhancing energy, mood, and cognitive function. The sustained-release mechanism of Ovaflip ensures a gradual release of DHEA into the bloodstream, providing a more stable and prolonged effect compared to immediate-release formulations. This can be particularly beneficial for individuals seeking to manage symptoms associated with hormonal imbalances, such as fatigue, mood swings, and decreased libido. In addition to its hormonal benefits, DHEA has been studied for its potential therapeutic effects in various medical fields. It may play a role in supporting cardiovascular health, enhancing immune function, and improving overall vitality. Ovaflip is particularly relevant in the fields of endocrinology and gynecology, where hormonal regulation is essential for reproductive health and metabolic function.
Ovaflip is a specialized formulation containing Dehydroepiandrosterone (DHEA) in a sustained-release (SR) format, designed to support hormonal balance and overall well-being. DHEA is a naturally occurring hormone produced by the adrenal glands, playing a crucial role in the synthesis of other hormones, including testosterone and estrogen. As individuals age, DHEA levels tend to decline, which can lead to various health issues. Ovaflip aims to replenish these levels, potentially enhancing energy, mood, and cognitive function.
The sustained-release mechanism of Ovaflip ensures a gradual release of DHEA into the bloodstream, providing a more stable and prolonged effect compared to immediate-release formulations. This can be particularly beneficial for individuals seeking to manage symptoms associated with hormonal imbalances, such as fatigue, mood swings, and decreased libido.
In addition to its hormonal benefits, DHEA has been studied for its potential therapeutic effects in various medical fields. It may play a role in supporting cardiovascular health, enhancing immune function, and improving overall vitality. Ovaflip is particularly relevant in the fields of endocrinology and gynecology, where hormonal regulation is essential for reproductive health and metabolic function.
Common side effects may include acne, hair loss, and changes in menstrual cycle. Consult a healthcare professional for a complete list of potential side effects.
Ovaflip is indicated for individuals experiencing symptoms related to low DHEA levels, including fatigue, mood disturbances, and decreased libido. It may also be beneficial for those seeking to support their overall hormonal health.
Consult a healthcare provider before starting Ovaflip, especially if you have a medical condition or are taking other medications.
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Composition : Alfacalcidol (0.50mcg) Capsule
Composition : Alfacalcidol (0.25mcg) Capsule
Composition : Folic Acid (1.5mg) + L-Carnitine L-Tartrate (500mg) + Methylcobalamin (1500mcg)
Composition : Methylcobalamin (1500mcg) Tablet
Composition : Methylcobalamin (1500mcg) + Alpha Lipoic Acid (100mg) + Vitamin B6 (Pyridoxine) (3mg) + Folic Acid (1.5mg) + Vitamin D3 (1000IU)
Composition : Myo Inositol 1000 mg + L-Methylfolate 100 mcg + Vitamin D3 1000 IU
Composition : S-adenosyl-L Methionine (400 mg)
Composition : L-Ornithine L-Aspartate (250mg) + Silymarin (70mg)
Composition : Collagen Peptide Type-I 40mg + Sodium Hyaluronate 30mg + Chondroitin Sulfate Sodium 200mg + Vitamin C 12.5mg + L-Arginine 500mg
Composition : Diacerein (50mg) + Glucosamine Sulfate Potassium Chloride (750mg) + Methyl Sulfonyl Methane (250mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Dehydroepiandrosterone 75 SR Tablet has growing demand in the gynecology, hormonal health, and wellness segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in hormonal imbalance management, fertility support, women’s health, and wellness therapies under medical supervision. It strengthens their gynecology and specialty care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dehydroepiandrosterone 75 SR Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady prescription demand, repeat sales, and growing awareness in hormonal wellness and fertility care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hormonal wellness formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.